Loading...
Emerging Markets And Aging Populations Will Expand Patient Access
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
17 Aug 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$118.67
22.6% undervalued intrinsic discount20 Aug
US$91.89
1Y
45.3%7D
2.0%1Y
45.3%7D
2.0%